Scores of amino acid 0D-3D information as applied in cleavage site prediction and better specificity elucidation for human immunodeficiency virus type 1 protease

被引:0
|
作者
LiFang Kang
GuiZhao Liang
Mao Shu
ShanBin Yang
ZhiLiang Li
机构
[1] Chongqing University,College of Bioengineering
[2] Chongqing University,College of Chemistry and Chemical Engineering
来源
关键词
score vector of zero dimension; one dimension; two dimensions and three dimensions (SZOTT); human immunodeficiency virus type 1 protease (HIV PR); linear discriminant analysis (LDA); support vector machine (SVM);
D O I
暂无
中图分类号
学科分类号
摘要
A new set of descriptors, namely score vectors of the zero dimension, one dimension, two dimensions and three dimensions (SZOTT), was derived from principle component analysis of a matrix of 1369 structural variables including 0D, 1D, 2D and 3D information for the 20 coded amino acids. SZOTT scales were then used in cleavage site prediction of human immunodeficiency virus type 1 protease. Linear discriminant analysis (LDA) and support vector machines (SVM) were applied to developing models to predict the cleavage sites. The results obtained by linear discriminant analysis (LDA) and support vector machines (SVM) are as follows. The Matthews correlation coefficients (MCC) by the resubstitution test, leave-one-out cross validation (LOOCV) and external validation are 0.879 and 0.911, 0.849 and 0.901, 0.822 and 0.846, respectively. The receiver operating characteristic (ROC) analysis showed that the SVM model possesses better simulative and predictive ability in comparison with the LDA model. Satisfactory results show that SZOTT descriptors can be further used to predict cleavage sites of human immunodeficiency virus type 1 protease.
引用
收藏
页码:794 / 800
页数:6
相关论文
共 50 条
  • [1] Scores of amino acid 0D-3D information as applied in cleavage site prediction and better specificity elucidation for human immunodeficiency virus type 1 protease
    Kang LiFang
    Liang GuiZhao
    Shu Mao
    Yang ShanBin
    Li ZhiLiang
    [J]. SCIENCE IN CHINA SERIES B-CHEMISTRY, 2008, 51 (08): : 794 - 800
  • [2] Scores of amino acid 0D-3D information as applied in cleavage site prediction and better specificity elucidation for human immunodeficiency virus type 1 protease
    KANG LiFang1
    2 College of Chemistry and Chemical Engineering
    [J]. Science China Chemistry, 2008, (08) : 794 - 800
  • [3] A new sequence representation as applied in better specificity elucidation for human immunodeficiency virus type 1 protease
    Liang, Gui Z.
    Li, Shengshi Z.
    [J]. BIOPOLYMERS, 2007, 88 (03) : 401 - 412
  • [4] Amino acid insertions in the flap of human immunodeficiency virus type 1-protease and resistance to protease inhibitors
    Affolabi, D
    Davi, M
    Gordien, E
    Dautin, N
    Hurez, D
    Ladant, D
    Deny, P
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S243 - S244
  • [5] Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance
    Kolli, Madhavi
    Stawiski, Eric
    Chappey, Colombe
    Schiffer, Celia A.
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (21) : 11027 - 11042
  • [6] 3-D QSAR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)PROTEASE INHIBITORS
    WALLER, CL
    OPREA, TI
    MARSHALL, GR
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 87 - MEDI
  • [7] Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease
    Pettit, SC
    Henderson, GJ
    Schiffer, CA
    Swanstrom, R
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (20) : 10226 - 10233
  • [8] Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir
    Côté, HCF
    Brumme, ZL
    Harrigan, PR
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (02) : 589 - 594
  • [9] Amino acid insertions near gag cleavage sites restore the otherwise compromised replication of human immunodeficiency virus type 1 variants resistant to protease inhibitors
    Tamiya, S
    Mardy, S
    Kavlick, MF
    Yoshimura, K
    Mistuya, H
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (21) : 12030 - 12040
  • [10] Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-Amino acids as P-2/P-3 ligands
    Jungheim, LN
    Shepherd, TA
    Baxter, AJ
    Burgess, J
    Hatch, SD
    Lubbehusen, P
    Wiskerchen, M
    Muesing, MA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 96 - 108